Pfizer Inc. warned doctors on Friday that one of its bestselling painkillers, Bextra, might increase the risk of a heart attack or stroke in coronary artery bypass surgery patients.
The issue of drug advertising directly aimed at consumers was thrust into the news recently when Merck withdrew its arthritis painkiller Vioxx from the market, citing studies indicating a risk of heart attacks or strokes.
Heavily advertised as an arthritis drug, Vioxx was pulled from the market last week after its maker said a study showed it doubled the risk of heart attack and stroke.
Merck &amp; Co. removed Vioxx from use Thursday after new study results showed increased risk of heart attacks and stroke in people who used it for longer than 18 mon
